How should CBT be integrated with pharmacotherapy for mood disorders?

• A. Coordinate with prescriber, use CBT to augment symptom relief and adherence, monitor interactions, and consider pharmacotherapy when indicated; ensure safety planning.
• B. Use CBT to replace pharmacotherapy entirely.
• C. Avoid monitoring interactions.
• D. Delay safety planning until after pharmacotherapy starts.

Answer: (A)

Integrating CBT with pharmacotherapy relies on collaborative, coordinated care that uses both approaches to maximize outcomes. The best approach is to work with the prescriber to determine when medications are indicated and to use CBT to augment symptom relief, improve coping skills, and support adherence to treatment. This means actively monitoring for medication interactions and side effects, adjusting the plan as needed, and using CBT techniques to reduce cognitive distortions, enhance behavioral activation, and prevent relapse. Safety planning should be part of the treatment from the start, given the risk of suicidality or worsening mood, so there’s a clear plan if risks arise.

Replacing pharmacotherapy with CBT alone is not typically appropriate for mood disorders, as meds often play a critical role in symptom reduction and stabilization. Ignoring medication interactions is unsafe, since some drugs can interact with substances or therapies and affect safety or efficacy. Delaying safety planning until after meds begin misses an essential safeguard; early safety planning helps manage risk across the treatment course.